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Non Hodgkins lymphoma (NHL) is a group of malignancies of the immune system with variable clinical
behaviors and diverse molecular features. Each year 56,000 new cases of NHL are diagnosed in the Unites
states with Small B cell Lymphoma (SBCL) comprising roughly one third of all cases. Unfortunately, the
incidence of NHL has increased over past decades, for unknown reasons, and is one of only two cancers
increasing in incidence. The SBCLs includes B-cell chronic lymphocytic leukemia (CLL), mantle cell
lymphoma (MCL) and low grade follicular lymphoma (FL). Current classification systems are based on
clinical staging, chromosomal abnormalities and cell surface antigen, and offer important diagnostic
information. However, there is still considerable overlap in biology, clinical behavior, genetic and epigenetic
alterations among the SBCLs. DNA methylation plays an important role in cancers by silencing a broad
spectrum of genes including tumor suppressor and DNA repair genes. In this study, we used a high
throughput approach to classify SBCL based on similarities in DNA methylation. Our data revealed that
there is diversity in DNA methylation among different SBCL subtypes, and some genes were preferentially
methylated in a subset -related manner. These differentially methylated genes might have diagnostic and
prognostic implications. This study provides the first insight into the global methylome of B-cell lymphomas. 
